Terms: = Uterine cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Staging
5 results:
1. Clinical Characteristics and Outcomes of a High-grade Endometrial cancer Cohort Treated at Instituto Nacional de Câncer, Brazil.
Paulino E; Melo AC
Rev Bras Ginecol Obstet; 2023 Jul; 45(7):e401-e408. PubMed ID: 37595597
[TBL] [Abstract] [Full Text] [Related]
2. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
[TBL] [Abstract] [Full Text] [Related]
3. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.
Multinu F; Casarin J; Cappuccio S; Keeney GL; Glaser GE; Cliby WA; Weaver AL; McGree ME; Angioni S; Faa G; Leitao MM; Abu-Rustum NR; Mariani A
Gynecol Oncol; 2019 Jul; 154(1):60-64. PubMed ID: 31126637
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
[TBL] [Abstract] [Full Text] [Related]
5. [Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].
Gottwald L; Chałubińska J; Moszyńska-Zielińska M; Piekarski J; Tyliński W; Szwalski J; Kubiak R; Pasz-Walczak G; Hendzel K; Ciałkowska-Rysz A
Ginekol Pol; 2011 Oct; 82(10):743-8. PubMed ID: 22379937
[TBL] [Abstract] [Full Text] [Related]